RecruitingN/AOther

Multiparametric Assessment to Investigate Prognostic Factors for Disease Evolution a nd Evolutionary Patterns of Cognitive Status in RRMS

Sponsored by University Hospital of Mont-Godinne

NCT ID
NCT05510817
Target Enrollment
50 participants
Start Date
2022-06-06
Est. Completion
2026-06-06

About This Study

This prospective study combining non conventional MRI techniques, neuropsychological screening tools, and a neurophysiological work-up using a sensitive and validated battery, will evaluate the predictive value of these measures and will explore the changes of the cognitive scores from baseline.

Conditions Studied

Multiple Sclerosis, Relapsing-Remitting

Interventions

  • Multiparametric assessment

Eligibility

Age:18 Years - 50 Years
Healthy Volunteers:No
View full eligibility criteria
Inclusion Criteria:

* active MS, according to the Lublin criteria
* disease duration \< 10 years before initiating or changing a disease-modifying therapies,
* relapse- and steroid-free for at least 1 month before MRI acquisition
* between 18-50 years old
* having given informed consent
* with no significant comorbidity other than MS or substance abuse that could interfere with cognitive performances

Exclusion Criteria:

* progressive forms of MS

Study Locations (1)

CHU UCL Namur site Godinne
Yvoir, Namur, Belgium

Interested in this trial?

Contact the study team to learn more about eligibility and enrollment.

View on ClinicalTrials.gov
Data Source
ClinicalTrials.gov

Last updated from source